V
Volker Thiel
Researcher at University of Bern
Publications - 184
Citations - 20160
Volker Thiel is an academic researcher from University of Bern. The author has contributed to research in topics: Coronavirus & Viral replication. The author has an hindex of 59, co-authored 170 publications receiving 14518 citations. Previous affiliations of Volker Thiel include University of St. Gallen & Universidad Iberoamericana (UNIBE).
Papers
More filters
Journal ArticleDOI
Coronavirus biology and replication: implications for SARS-CoV-2.
TL;DR: The first discoveries that shape the current understanding of SARS-CoV-2 infection throughout the intracellular viral life cycle are summarized and relate that to the knowledge of coronavirus biology.
Journal ArticleDOI
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj,Huihui Mou,Saskia L. Smits,Dick H. W. Dekkers,Marcel A. Müller,Ronald Dijkman,Doreen Muth,Jeroen Demmers,Ali Moh Zaki,Ron A. M. Fouchier,Volker Thiel,Volker Thiel,Christian Drosten,Peter J. M. Rottier,Albert D. M. E. Osterhaus,Berend Jan Bosch,Bart L. Haagmans +16 more
TL;DR: Dipeptidyl peptidase 4 (DPP4; also known as CD26) is identified as a functional receptor for hCoV-EMC and will contribute critically to the understanding of the pathogenesis and epidemiology of this emerging human coronavirus, and may facilitate the development of intervention strategies.
Journal ArticleDOI
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.
Eric J. Snijder,Peter J. Bredenbeek,Jessika C. Dobbe,Volker Thiel,John Ziebuhr,Leo L.M. Poon,Yi Guan,Mikhail Rozanov,Willy J. M. Spaan,Alexander E. Gorbalenya +9 more
TL;DR: These newly recognized viral enzymes place the mechanism of coronavirus RNA synthesis in a completely new perspective and will be important targets for the design of antiviral strategies aimed at controlling the further spread of SARS-CoV.
Journal ArticleDOI
Mechanisms and enzymes involved in SARS coronavirus genome expression.
Volker Thiel,Konstantin A. Ivanov,Ákos Putics,Tobias Hertzig,Barbara Schelle,Sonja Bayer,Benedikt Weißbrich,Eric J. Snijder,Holger F. Rabenau,Hans Wilhelm Doerr,Alexander E. Gorbalenya,John Ziebuhr +11 more
TL;DR: The availability of recombinant forms of key replicative enzymes of SARS coronavirus should pave the way for high-throughput screening approaches to identify candidate inhibitors in compound libraries.
Journal ArticleDOI
2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members
Stephane Daffis,Kristy J. Szretter,Jill Schriewer,Jianqing Li,Soonjeon Youn,John S. Errett,Tsai-Yu Lin,Stewart W. Schneller,Roland Züst,Hongping Dong,Volker Thiel,Volker Thiel,Ganes C. Sen,Volker Fensterl,William B. Klimstra,Theodore C. Pierson,R. Mark L. Buller,Michael Gale,Pei Yong Shi,Michael S. Diamond +19 more
TL;DR: It is demonstrated that a West Nile virus mutant that lacks 2′-O MTase activity was attenuated in wild-type primary cells and mice but was pathogenic in the absence of type I interferon (IFN) signalling, and suggested an evolutionary explanation for 2-O methylation of cellular mRNA: to distinguish self from non-self RNA.